[Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, benserazide-HCl, on Parkinson's disease--Part II: Pharmacokinetic study (author's transl)].
作者信息
Yokochi M, Kondo T, Hirayama K, Narabayashi H, Kuruma I